Synjardy is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Empagliflozin; Metformin Hydrochloride.
| Product ID | 0597-0159_2f7eaca8-aa25-162f-af59-8682293e8590 |
| NDC | 0597-0159 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Synjardy |
| Generic Name | Empagliflozin And Metformin Hydrochloride |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-08-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA206111 |
| Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Substance Name | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
| Active Ingredient Strength | 5 mg/1; mg/1 |
| Pharm Classes | Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],Biguanide [EPC],Biguanides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2015-09-12 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA206111 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-09-12 |
| Marketing Category | NDA |
| Application Number | NDA206111 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-09-12 |
| Marketing Category | NDA |
| Application Number | NDA206111 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-09-12 |
| Ingredient | Strength |
|---|---|
| EMPAGLIFLOZIN | 5 mg/1 |
| SPL SET ID: | 0fdd0255-0055-65f3-b2c0-db8fbb87beae |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0597-0159 | Synjardy | empagliflozin and metformin hydrochloride |
| 0597-0168 | Synjardy | empagliflozin and metformin hydrochloride |
| 0597-0175 | Synjardy | empagliflozin and metformin hydrochloride |
| 0597-0180 | Synjardy | empagliflozin and metformin hydrochloride |
| 0597-0280 | Synjardy | empagliflozin, metformin hydrochloride |
| 0597-0290 | Synjardy | empagliflozin, metformin hydrochloride |
| 0597-0295 | Synjardy | empagliflozin, metformin hydrochloride |
| 0597-0300 | Synjardy | empagliflozin, metformin hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SYNJARDY 79145490 4590924 Live/Registered |
Boehringer Ingelheim International GmbH 2014-02-17 |